U.S. Pharma Stock News

Full year 2025 earnings reset the conversation Civitas Resources (CIVI) recently reported full year 2025 results, with revenue of US$4,393 million and net income of US$561 million, both lower than the prior year, putting the stock back under closer investor review. See our latest analysis for Civitas Resources. At a share price of US$27.38, Civitas Resources has seen a 5.0% decline in its 90 day share price return and a 43.4% drop in its 1 year total shareholder return. This suggests momentum...

Q4 earnings and capital moves put MGIC Investment (MTG) in the spotlight MGIC Investment (MTG) drew investor attention after its recent earnings update, which paired flat year over year revenue and an earnings figure in line with expectations, along with a modest post report share price drop. See our latest analysis for MGIC Investment. At a share price of US$26.52, MGIC Investment has seen its short term share price momentum soften, with a year to date share price return of a 9.02% decline...

In late February 2026, Flywire reported fourth-quarter 2025 sales of US$157.54 million and net income of US$0.033 million, alongside full-year 2025 sales of US$623.03 million and net income of US$13.5 million, issued 2026 growth guidance, filed a US$77.86 million ESOP-related shelf registration, and reshaped its technology leadership. The appointment of seasoned payments technologist Patrick Blanc as Chief Technology Officer, coupled with Flywire’s AI-first engineering push and Student...

The Morning Bull - US Market Morning Update Monday, Mar, 9 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 1.3% and Nasdaq 100 futures off roughly 1.5%, as investors react to a jump in borrowing costs and energy prices. The US 10 year Treasury yield is around 4.22%, meaning mortgages, car loans, and corporate borrowing can all stay more expensive for longer, while oil above US$100 keeps pressure on fuel and transport costs. With Middle East...

Dillard’s, Inc. recently reported fourth-quarter and full-year results showing slightly lower sales, revenue and net income compared with the prior year, while its board declared a US$0.30 per-share dividend payable in May 2026. Alongside these results, Dillard’s completed a sizeable share repurchase program and launched the exclusive Amanda Jones Vaughan x Antonio Melani capsule collection across its stores and online. With earnings modestly softer and a fresh exclusive fashion...

Recent coverage of American Superconductor (AMSC) has focused on its shift toward power systems for energy grids and naval technology, where consistent double-digit sales growth and stronger cash generation are drawing fresh investor attention. See our latest analysis for American Superconductor. Even after a sharp 10.2% one day share price decline and a 12.3% year to date share price pullback to about US$27.70, American Superconductor still carries a 57.9% one year total shareholder return...

Why RONN Stock Is On Traders’ Radar RONN (RONN) has drawn attention after sharp recent swings, with returns around 99% over the past week and past 3 months, putting this small zero emission vehicle developer back in focus for speculative investors. See our latest analysis for RONN. That surge in recent share price returns over the past week and past quarter comes after a much tougher stretch, with the 1 year total shareholder return still showing a 50% decline. This highlights how quickly...

Ryan Specialty Holdings (RYAN) is back in focus after reporting 2025 revenue of more than US$3.05b, completing five acquisitions, and launching its three year Empower Program to streamline operations and cut costs. See our latest analysis for Ryan Specialty Holdings. Despite the Empower Program and recent acquisitions getting attention, Ryan Specialty Holdings’ 1 day share price return of 1% and 7 day share price return of 0.9% sit against a 30 day share price decline of 16.4%, a year to date...

If you are wondering whether Bel Fuse shares still offer value after a strong run, this article explains what the current price might be implying about the business. The stock closed at US$172.94 recently, with a 7 day return of an 18.4% decline and a 30 day return of a 16.0% decline, while the 1 year return sits at 119.7% and the 3 year return is very large. These price moves sit against a backdrop of ongoing attention on Bel Fuse within the tech sector, as investors reassess companies that...

If you are wondering whether Microsoft is still fairly priced after its long run as a market heavyweight, looking closely at its current valuation can help you decide how it might fit into your portfolio. The stock last closed at US$408.96, with returns of 2.6% over the past 7 days, 1.9% over the past 30 days, a year-to-date return of a 13.5% decline, and 8.4% over the past year. The 3-year and 5-year returns sit at 64.9% and 81.5% respectively. Recent headlines around Microsoft have focused...

On February 24, 2026, Brady Corporation’s board declared a US$0.245 per-share dividend on Class A common stock, payable April 30, 2026, to shareholders of record as of April 9, 2026. This dividend decision comes alongside multi-year growth in sales, earnings, and free cash flow, underscoring Brady’s capacity to return cash to investors. We’ll now examine how Brady’s dividend declaration, against a backdrop of solid multi-year earnings and cash flow growth, influences its investment...

In a recent filing, Eva Live announced it secured $7 million in growth financing, another step closer to advancing the company’s broader investment narrative.

Recent share performance and business snapshot With no single headline event driving attention to Veris Residential (VRE), the recent share performance itself is the focus, as the stock shows double digit returns over the past month and past 3 months. Veris Residential is a real estate investment trust focused on Class A multifamily properties in the Northeast. It uses a technology enabled, vertically integrated platform to manage, operate, acquire, and develop its portfolio for residents and...

Certara recently highlighted that its Simcyp physiologically-based pharmacokinetic modeling was accepted by the U.S. FDA in place of multiple clinical pharmacology studies to support the new drug application for asciminib (Scemblix®), an allosteric BCR::ABL1 inhibitor for Chronic Myeloid Leukemia. This decade-long modeling effort, which replaced at least ten dedicated clinical studies and informed dosing and drug-interaction decisions, underscores how biosimulation can cut development costs...

What triggered fresh interest in Xeris Biopharma Holdings (XERS)? Xeris Biopharma Holdings (XERS) has drawn fresh attention after reporting fourth quarter and full year 2025 results that moved from loss to profit, paired with new 2026 revenue guidance and a US$40.7 million shelf registration filing. See our latest analysis for Xeris Biopharma Holdings. Despite Xeris Biopharma Holdings posting improved earnings and setting 2026 revenue guidance, recent share price returns have been weak, with...

MarketAxess Holdings Inc. recently appointed William Quan as Chief Technology Officer, tasking him with modernizing its global technology platforms and embedding AI and advanced data capabilities across the business. By bringing in a leader with deep experience in electronic trading and AI-driven platforms from firms like Amazon Web Services, J.P. Morgan, and Deutsche Bank, MarketAxess is signaling a stronger push to enhance its bond-trading technology and product innovation. With William...

In recent days, investor concerns about regional banks’ exposure to the opaque private credit market have weighed on The Bancorp, amid broader sector jitters following defaults and loan write-offs in that space. These worries come on top of earlier pressure from weaker quarterly results and a shrinking net interest margin, even as The Bancorp has built a niche in specialized fintech-focused banking and lending solutions. Next, we’ll examine how heightened worries about private credit...

In February 2026, Xylem Inc. announced that its Board of Directors had approved a new share repurchase program, authorizing the company to buy back up to US$1.50 billion of its own stock with no expiration date. This move follows the completion of a prior authorization under which Xylem repurchased 5,200,000 shares for US$321.90 million, highlighting an ongoing preference for returning capital to shareholders alongside reinvestment in the business. We’ll now explore how this sizable,...

In late February 2026, SS&C Technologies Holdings, Inc. reported an 8.1% year-on-year revenue increase that exceeded analyst expectations and raised its full-year EPS and revenue guidance, citing strong execution and the breadth of its software and services portfolio. A few days earlier, SS&C announced a generative AI-powered sales enablement solution developed with Thornburg Investment Management, embedding advisor insights directly into CRM systems to streamline how asset managers prepare...

Why Brixmor Property Group Stock Is On Investors’ Radar Brixmor Property Group (BRX) has drawn fresh attention after recent trading left the stock with a month return of 6.2% and a past 3 months move of 21.9%, prompting closer scrutiny of the REIT’s fundamentals. See our latest analysis for Brixmor Property Group. At a share price of US$30.07, Brixmor’s recent 6.2% 1 month and 21.9% 3 month share price returns contrast with some softer short term moves. Its 1 year and multi year total...

DT Midstream (DTM) has drawn fresh attention after reporting 17% year-over-year adjusted EBITDA growth for 2025, expanding its Pipeline segment to 70% of the business and raising its quarterly dividend by 7.3%. See our latest analysis for DT Midstream. The latest operational update seems to line up with recent market interest, with a 30 day share price return of 10.1% and a 90 day share price return of 17.5%. The 1 year total shareholder return of 65.6% and 3 year total shareholder return of...

In early March 2026, SES AI Corporation reported full-year 2025 results showing sales of US$21.00 million, a smaller net loss of US$73.04 million, a Q4 revenue shortfall versus expectations, and new 2026 revenue guidance of US$30.00 million to US$35.00 million alongside a projected reset in gross margins. The earnings release also revealed a pivot away from automotive battery mass production toward energy storage systems, drones, and materials, while logistics-driven shipment delays and...

Vulcan Materials (NYSE:VMC) reported quarterly results that came in below expectations, alongside softer guidance for the near term. J.P. Morgan downgraded the stock and flagged the possibility that demand growth could stay subdued until 2027. Short interest in Vulcan Materials has risen, pointing to increased bearish positioning in the shares. Vulcan Materials, trading at $274.99, is coming off a tough stretch, with the stock down 11.3% over the past week and 15.1% over the past month...

In recent days, Commerce Bancshares (NASDAQ: CBSH) has come into focus after an analyst rating upgrade and shifts in institutional portfolios around the regional bank. This attention, framed by comparisons to trends linked to the Nasdaq 100 index, has intensified discussion of how Commerce Bancshares fits into broader banking exposure. We will now examine how the recent analyst upgrade, alongside institutional portfolio changes, could shape Commerce Bancshares’ evolving investment...